Clinical Trial Update: Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating acid suppression therapy for laryngomalacia and Gastroesophageal reflux disease was terminated, with results posted in July 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Laryngomalacia

Snippet

Sponsor: Reema Padia | Conditions: Laryngomalacia, Gastro Esophageal Reflux | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-07-20